Different medications for AFIB, Lecture notes of Nursing

Provides medications that manage and treat AFIb

Typology: Lecture notes

2024/2025

Uploaded on 04/22/2026

michaella-clark
michaella-clark 🇺🇸

9 documents

1 / 3

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Rate Control Medications
Medication
Classification
Indication
Dosage
Nursing
Implications
Patient Education
Diltiazem
Calcium
Channel Blocker
Acute
RVR in
AFib
IV: Initial
0.25 mg/kg
bolus over 2
minutes, may
repeat in 15
minutes.
Continuous
infusion: 5-15
mg/h. Oral:
120-360 mg
daily
Monitor BP and
HR before
administration.
Caution in
patients with
heart failure.
Watch for
hypotension and
bradycardia.
Avoid grapefruit
juice. Do not stop
abruptly. Report
dizziness, fainting,
or an irregular
heartbeat.
Metoprolol
Beta-Blocker
Acute
RVR in
AFib; Rate
control
IV: 2.5-5 mg
every 2-5
minutes for a
total of 15
mg. Oral: 25-
100 mg BID
Monitor BP and
HR before and
after
administration.
Caution in
patients with
asthma or
COPD. Watch
for hypotension
and bradycardia.
Take with food. Do
not stop abruptly.
Report difficulty
breathing, dizziness,
or unusual fatigue.
Digoxin
Cardiac
Glycoside
Rate
control in
AFib,
especially
with heart
failure
IV: 0.25 mg
every 2 hours
up to a total
dose of 1.5
mg. Oral:
0.125-0.25
mg daily
Monitor HR and
ECG for
arrhythmias.
Assess for signs
of digoxin
toxicity (nausea,
vomiting, visual
disturbances).
Monitor
potassium levels.
Take at the same
time each day.
Report symptoms of
toxicity, such as
blurred vision or
nausea. Maintain
consistent dietary
potassium intake.
Esmolol
Beta-Blocker
Acute
RVR in
AFib
IV: 500
mcg/kg bolus
over 1
minute,
followed by
50-200
mcg/kg/min
infusion
Monitor BP, HR,
and ECG during
administration.
Watch for
hypotension and
bradycardia.
Inform healthcare
provider of any
breathing difficulties
or dizziness. Report
any signs of a slow
or irregular
heartbeat.
pf3

Partial preview of the text

Download Different medications for AFIB and more Lecture notes Nursing in PDF only on Docsity!

Rate Control Medications

Medication Classification Indication Dosage Nursing Implications

Patient Education

Diltiazem Calcium Channel Blocker

Acute RVR in AFib

IV: Initial 0.25 mg/kg bolus over 2 minutes, may repeat in 15 minutes. Continuous infusion: 5- mg/h. Oral: 120-360 mg daily

Monitor BP and HR before administration. Caution in patients with heart failure. Watch for hypotension and bradycardia.

Avoid grapefruit juice. Do not stop abruptly. Report dizziness, fainting, or an irregular heartbeat.

Metoprolol Beta-Blocker Acute RVR in AFib; Rate control

IV: 2.5-5 mg every 2- minutes for a total of 15 mg. Oral: 25- 100 mg BID

Monitor BP and HR before and after administration. Caution in patients with asthma or COPD. Watch for hypotension and bradycardia.

Take with food. Do not stop abruptly. Report difficulty breathing, dizziness, or unusual fatigue.

Digoxin Cardiac Glycoside

Rate control in AFib, especially with heart failure

IV: 0.25 mg every 2 hours up to a total dose of 1. mg. Oral: 0.125-0. mg daily

Monitor HR and ECG for arrhythmias. Assess for signs of digoxin toxicity (nausea, vomiting, visual disturbances). Monitor potassium levels.

Take at the same time each day. Report symptoms of toxicity, such as blurred vision or nausea. Maintain consistent dietary potassium intake.

Esmolol Beta-Blocker Acute RVR in AFib

IV: 500

mcg/kg bolus over 1 minute, followed by 50- mcg/kg/min infusion

Monitor BP, HR, and ECG during administration. Watch for hypotension and bradycardia.

Inform healthcare provider of any breathing difficulties or dizziness. Report any signs of a slow or irregular heartbeat.

Rhythm Control Medications

Medication Classification Indication Dosage Nursing Implications

Patient Education Amiodarone Antiarrhythmic Acute RVR in AFib; Rhythm control

IV: 150

mg over 10 minutes, then 1 mg/min for 6 hours, then 0. mg/min. Oral: 200- mg daily

Monitor ECG, BP, and HR. Watch for signs of pulmonary toxicity, liver dysfunction, and thyroid abnormalities.

Avoid grapefruit juice. Use sunscreen to prevent photosensitivity. Report symptoms like cough, shortness of breath, or vision changes.

Sotalol Beta- Blocker/Antiarrhythmic

Maintenance of sinus rhythm in AFib

Oral: 80- mg BID

Monitor QT interval due to the risk of torsades de pointes. Monitor renal function as dosing may require adjustment.

Avoid activities requiring alertness if dizzy. Report symptoms like chest pain, palpitations, or fainting.

Anticoagulants

Medication Classification Indication Dosage Nursing Implications

Patient Education

Apixaban Oral Anticoagulant Stroke prevention in non-

Oral: 5 mg BID (2.5 mg BID for patients with

Monitor for signs of bleeding. Assess renal

Take as prescribed, with or without food. Report any signs of bleeding (e.g.,